Shattuck Labs Inc expected to post a loss of 12 cents a share - Earnings Preview
Shattuck Labs Inc expected to post a loss of 12 cents a share - Earnings Preview
Shattuck Labs Inc STTK.OQ STTK.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Shattuck Labs Inc is for a loss of 12 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Shattuck Labs Inc is $16.50, about 127% above its last closing price of $7.27
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.13 | -0.14 | -0.13 | Beat | 5.9 |
Dec. 31 2026 | -0.14 | -0.14 | -0.12 | Beat | 12.2 |
Sep. 30 2025 | -0.14 | -0.15 | -0.14 | Beat | 5.8 |
Jun. 30 2025 | -0.25 | -0.24 | -0.24 | Met | 2 |
Mar. 31 2025 | -0.31 | -0.28 | -0.27 | Beat | 4 |
Dec. 31 2024 | -0.30 | -0.32 | -0.37 | Missed | -15.8 |
Sep. 30 2024 | -0.41 | -0.42 | -0.33 | Beat | 20.8 |
Jun. 30 2024 | -0.42 | -0.41 | -0.42 | Missed | -1.6 |
This summary was machine generated August 10 at 13:25 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Shattuck Labs
See all newsBrief: Shattuck Labs Announces Phase 2 Clinical Trial Of Sl-325 In Hidradenitis Suppurativa And Appointment Of Shoba Ravichandran, M.D., As Senior Vice President, Clinical Development
Shattuck Labs Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health